SDHB Mutation Status and Tumor Size but Not Tumor Grade Are Important Predictors of Clinical Outcome in Pheochromocytoma and Abdominal Paraganglioma.

Authors

Yasmine Assadipour, George Washington University
Samira M Sadowski
Meghna Alimchandani
Martha Quezado
Seth M Steinberg
Naris Nilubol
Dhaval Patel
Tamara Prodanov
Karel Pacak
Electron Kebebew

Document Type

Journal Article

Publication Date

1-1-2017

Journal

Surgery

Volume

161

Issue

1

DOI

10.1016/j.surg.2016.05.050

Keywords

Adrenal Gland Neoplasms; Adult; Aged; Biopsy, Needle; Cohort Studies; Databases, Factual; Digestive System Neoplasms; Disease-Free Survival; Female; Genetic Testing; Germ-Line Mutation; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Grading; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Succinate Dehydrogenase; Survival Analysis; Tumor Burden

APA Citation

Assadipour, Y., Sadowski, S., Alimchandani, M., Quezado, M., Steinberg, S., Nilubol, N., Patel, D., Prodanov, T., Pacak, K., & Kebebew, E. (2017). SDHB Mutation Status and Tumor Size but Not Tumor Grade Are Important Predictors of Clinical Outcome in Pheochromocytoma and Abdominal Paraganglioma.. Surgery, 161 (1). http://dx.doi.org/10.1016/j.surg.2016.05.050

Peer Reviewed

1